These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 11705886

  • 1. Bimodal effects of 1R,2R-diaminocyclohexane(trans-diacetato)(dichloro)platinum(IV) on cell cycle checkpoints.
    Kuang J, He G, Huang Z, Khokhar AR, Siddik ZH.
    Clin Cancer Res; 2001 Nov; 7(11):3629-39. PubMed ID: 11705886
    [Abstract] [Full Text] [Related]

  • 2. Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV).
    Hagopian GS, Mills GB, Khokhar AR, Bast RC, Siddik ZH.
    Clin Cancer Res; 1999 Mar; 5(3):655-63. PubMed ID: 10100719
    [Abstract] [Full Text] [Related]

  • 3. Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities.
    He G, Siddik ZH, Huang Z, Wang R, Koomen J, Kobayashi R, Khokhar AR, Kuang J.
    Oncogene; 2005 Apr 21; 24(18):2929-43. PubMed ID: 15735718
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
    Siddik ZH, al-Baker S, Thai G, Khokhar AR.
    Anticancer Drug Des; 1994 Apr 21; 9(2):139-51. PubMed ID: 8166929
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.
    Ali MS, Khan SR, Ojima H, Guzman IY, Whitmire KH, Siddik ZH, Khokhar AR.
    J Inorg Biochem; 2005 Mar 21; 99(3):795-804. PubMed ID: 15708801
    [Abstract] [Full Text] [Related]

  • 10. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
    Rao S, Lowe M, Herliczek TW, Keyomarsi K.
    Oncogene; 1998 Nov 05; 17(18):2393-402. PubMed ID: 9811471
    [Abstract] [Full Text] [Related]

  • 11. Blockade of tumor cell transforming growth factor-betas enhances cell cycle progression and sensitizes human breast carcinoma cells to cytotoxic chemotherapy.
    Ohmori T, Yang JL, Price JO, Arteaga CL.
    Exp Cell Res; 1998 Dec 15; 245(2):350-9. PubMed ID: 9851876
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
    Yin MB, Guo B, Panadero A, Frank C, Wrzosek C, Slocum HK, Rustum YM.
    Exp Cell Res; 1999 Feb 25; 247(1):189-99. PubMed ID: 10047461
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate.
    Liang YC, Lin-Shiau SY, Chen CF, Lin JK.
    J Cell Biochem; 1999 Oct 01; 75(1):1-12. PubMed ID: 10462699
    [Abstract] [Full Text] [Related]

  • 15. The impact of S- and G2-checkpoint response on the fidelity of G1-arrest by cisplatin and its comparison to a non-cross-resistant platinum(IV) analog.
    He G, Kuang J, Khokhar AR, Siddik ZH.
    Gynecol Oncol; 2011 Aug 01; 122(2):402-9. PubMed ID: 21592546
    [Abstract] [Full Text] [Related]

  • 16. Troglitazone inhibits growth of MCF-7 breast carcinoma cells by targeting G1 cell cycle regulators.
    Yin F, Wakino S, Liu Z, Kim S, Hsueh WA, Collins AR, Van Herle AJ, Law RE.
    Biochem Biophys Res Commun; 2001 Sep 07; 286(5):916-22. PubMed ID: 11527386
    [Abstract] [Full Text] [Related]

  • 17. Differential regulation of the synthesis and activity of the major cyclin-dependent kinases, p34cdc2, p33cdk2, and p34cdk4, during cell cycle entry and progression in normal human T lymphocytes.
    Lucas JJ, Szepesi A, Domenico J, Tordai A, Terada N, Gelfand EW.
    J Cell Physiol; 1995 Nov 07; 165(2):406-16. PubMed ID: 7593219
    [Abstract] [Full Text] [Related]

  • 18. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells.
    Morris TA, DeLorenzo RJ, Tombes RM.
    Exp Cell Res; 1998 May 01; 240(2):218-27. PubMed ID: 9596994
    [Abstract] [Full Text] [Related]

  • 19. Flavopiridol down-regulates antiapoptotic proteins and sensitizes human breast cancer cells to epothilone B-induced apoptosis.
    Wittmann S, Bali P, Donapaty S, Nimmanapalli R, Guo F, Yamaguchi H, Huang M, Jove R, Wang HG, Bhalla K.
    Cancer Res; 2003 Jan 01; 63(1):93-9. PubMed ID: 12517783
    [Abstract] [Full Text] [Related]

  • 20. Evidence for a p23 caspase-cleaved form of p27[KIP1] involved in G1 growth arrest.
    Loubat A, Rochet N, Turchi L, Rezzonico R, Far DF, Auberger P, Rossi B, Ponzio G.
    Oncogene; 1999 Jun 03; 18(22):3324-33. PubMed ID: 10362353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.